Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Other financing activities (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Other financing activities for 1 consecutive years, with $3.2 million as the latest value for Q3 2024.

  • On a quarterly basis, Other financing activities changed N/A to $3.2 million in Q3 2024 year-over-year; TTM through Apr 2025 was $3.2 million, a N/A change, with the full-year FY2025 number at $3.2 million, up 37.02% from a year prior.
  • Other financing activities was $3.2 million for Q3 2024 at Kestra Medical Technologies, up from $1000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $3.2 million in Q3 2024 to a low of $1000.0 in Q2 2024.